High prevalence of chronic kidney disease in Iran: a large population-based study

[1] Coresh J(2007)Prevalence of Chronic Kidney Disease in the United States JAMA 298 2038-2047

[2] Selvin E(2008)Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population Am J Epidemiol 167 1226-1234

[3] Stevens LA(2004)Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 659-663

[4] Manzi J(2001)Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988 – 1994) Arch Intern Med 161 1207-1216

[5] Kusek JW(2001)Management of patients with chronic renal insufficiency in the Northeastern United States J Am Soc Nephrol 12 1501-1507

[6] Eggers P(1997)Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practice and published guidelines Am J Kidney Dis 29 368-375

[7] Van Lente F(2004)Angiotensin-receptor blockade versus convertingenzyme inhibition in type 2 diabetes and nephropathy N Engl J Med 351 1952-1961

[8] Levey AS(2000)Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo controlled trials AM J Kidney Dis 35 695-707

[9] Astor BC(2001)Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data Ann Intern Med 135 73-87

[10] Schmid H(2003)Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study J Am Soc Nephrol 14 S131-S138

[1] Coresh J(2007)Prevalence of Chronic Kidney Disease in the United States JAMA 298 2038-2047

[2] Selvin E(2008)Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population Am J Epidemiol 167 1226-1234

[3] Stevens LA(2004)Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 659-663

[4] Manzi J(2001)Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988 – 1994) Arch Intern Med 161 1207-1216

[5] Kusek JW(2001)Management of patients with chronic renal insufficiency in the Northeastern United States J Am Soc Nephrol 12 1501-1507

[6] Eggers P(1997)Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practice and published guidelines Am J Kidney Dis 29 368-375

[7] Van Lente F(2004)Angiotensin-receptor blockade versus convertingenzyme inhibition in type 2 diabetes and nephropathy N Engl J Med 351 1952-1961

[8] Levey AS(2000)Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo controlled trials AM J Kidney Dis 35 695-707

[9] Astor BC(2001)Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data Ann Intern Med 135 73-87

[10] Schmid H(2003)Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study J Am Soc Nephrol 14 S131-S138